EDUARDO
PÉREZ GÓMEZ
Profesor titular de universidad
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (10)
2019
-
Therapeutic targeting of HER2–CB 2 R heteromers in HER2-positive breast cancer
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 9, pp. 3863-3872
-
Erratum: Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (3863–3872) DOI: 10.1073/pnas.1815034116)
Proceedings of the National Academy of Sciences of the United States of America
-
S194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma
Carcinogenesis, Vol. 40, Núm. 10, pp. 1260-1268
2018
-
Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer
Biochemical Pharmacology, Vol. 157, pp. 285-293
2016
-
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer
Oncotarget, Vol. 7, Núm. 30, pp. 47565-47575
2015
-
Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin α-sarcin in nude mice bearing human colorectal cancer xenografts
SpringerPlus, Vol. 4, Núm. 1
-
Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation
Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 131-144
-
New inhibitors of angiogenesis with antitumor activity in vivo
Journal of Medicinal Chemistry, Vol. 58, Núm. 9, pp. 3757-3766
-
Role of cannabinoid receptor CB<inf>2</inf> in HER2 pro-oncogenic signaling in breast cancer
Journal of the National Cancer Institute, Vol. 107, Núm. 6
2014
-
Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling
Journal of Biological Chemistry, Vol. 289, Núm. 32, pp. 21960-21972